Skip to content
2000
Volume 20, Issue 28
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Probiotics are nowadays frequently used by patients with inflammatory bowel disease, however literature data are conflicting related to their importance. In mild to moderate ulcerative colitis probiotics can be used effectively in induction and maintaining remission, and prevention of pouchitis. As the other side of the shield, there is not sufficient evidence to support the use of probiotics in daily clinical practice in Crohn’s disease. The aim of the present review is to provide help for clinicians about the probiotic use in patients with inflammatory bowel disease. The comparison of literature data is limited by the large number of probiotic strains, various combined preparations, and different doses applied in the clinical studies. Small number of comparable protocols and lack of standardization encumber the analysis of study results.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/13816128113196660727
2014-08-01
2025-05-25
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/13816128113196660727
Loading

  • Article Type:
    Research Article
Keyword(s): inflammatory bowel disease; Probiotics
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test